Metrics to compare | INGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.5x | −13.1x | −0.5x | |
PEG Ratio | −0.20 | −0.09 | 0.00 | |
Price/Book | 1.0x | 6.0x | 2.6x | |
Price / LTM Sales | 0.6x | 4.5x | 3.2x | |
Upside (Analyst Target) | 68.3% | 70.4% | 48.8% | |
Fair Value Upside | Unlock | −11.8% | 6.9% | Unlock |
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.